Mark Baglin Email Address

Chief Commercial Officer

Learn about Alnylam Pharmaceuticals, RNAi therapeutics, and the company's efforts in treating amyloidosis, hemophilia, and porphyria.

I am a true T-shaped healthcare leader anchored in the commercial area - deep functional knowledge, coupled with a broad and mature ability to effectively align and lead across the full breadth of the organization Multiple successes in Pharmaceutical, Biotechnology and Medical Device commercial and franchise leadership, including bringing a new class of RNAi therapeutics to market globally, as well as building a Rare Disease franchise from scratch to become a $1bn+ global business. Multiple corporate award winner and recipient of the highest performance ratings, I have successfully developed, launched and commercialized a number of major brands, both domestically and internationally in multiple therapeutic areas I focus on building trust and credibility with internal and external stakeholders, on development of a shared vision, clear direction and on demonstration of measurement of progress.